Drug · DIN 02459647
OMNITROPE
CARTRIDGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 14, 2017; first marketed August 14, 2017.
- Drug Identification Number (DIN)
- 02459647
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Somatropin H01AC01
- Class
- Human
- Record last updated
- August 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SOMATROPIN | 15 MG | 1.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 12, 2016: NOC 18774Supplement to a New Drug Submission (SNDS) · New strength 15mg/1.5ml
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “omnitrope”. A notice may cover another product or only some lots: read it to see what it covers.
- Two lots of Omnitrope injectable human growth hormone recalled due to cracked cartridgesJuly 8, 2026 · Biologic or vaccine · Product quality · Type I
Other DINs named OMNITROPE
- DIN 02325063 · Marketed
- DIN 02325071 · Marketed
- DIN 02325055 · Cancelled Pre Market